News

Presidio has said that the inhibitors of the HCV NS5A protein represent an exciting, highly potent class that is distinct from other classes of HCV antivirals that target

PAPs primarily serve uninsured patients who may not qualify for government-funded programs and cannot afford their medications. Because PAPs are offered by pharmaceutical companies that determine program criteria,

Dr Dixon’s prior experience include 30 years in the biopharmaceutical industry involving multiple product launches and new drug approvals across a broad range of therapeutic areas and the

So far COQ10 products were available mostly as soft-gel capsules or as tablets. Elder said that its R&D centre worked extensively on the development of a chewable form

VITL’s recognition of athenahealth as a preferred EHR partner means athenahealth demonstrated the ability to share clinical data via the Vermont Health Information Exchange. athenahealth’s web-based EHR service,

Vimovo is approved for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients

Nippon Boehringer Ingelheim and Astellas said that they are committed to further contribute to the treatment of hypertension by further enhancing the promotion of the Micardis family. Micardis

HealthSport and SMI Manufacturing said that the merger is expected to result in a company into developing and producing oral thin film for the delivery of dietary supplements

Headquartered in Phillipsburg, New Jersey, Covidien’s specialty chemicals business, manufactures and markets high-purity chemicals and related products and services under two brand names, JT Baker and Mallinckrodt Laboratory